U.S. Insurance Stock News

Investor attention on IREN (NasdaqGS:IREN) has intensified after its US$9.7b AI cloud contract with Microsoft, as the former Bitcoin miner recasts itself as an AI infrastructure provider and faces scrutiny over funding, GPU build out, and upcoming earnings. See our latest analysis for IREN. At a last close of US$53.74, IREN has seen a sharp pullback with a 1 day share price return of 10.19% decline and a 7 day share price return of 5.19% decline. However, its 30 day share price return of...

United Bancorporation of Alabama (UBAB) closed out FY 2025 with fourth quarter revenue of about US$17.3 million and basic EPS of US$1.15, alongside trailing twelve month revenue of roughly US$69.7 million and EPS of US$5.23 that frame the latest numbers in a wider context. Over the past few quarters, revenue has ranged from about US$16.8 million to US$18.0 million while quarterly EPS has moved between US$1.15 and US$1.42, providing a clear view of how the income statement has been tracking...

F & M Bank (FMBM) has wrapped up FY 2025 with fourth quarter revenue of US$12.8 million and EPS of US$0.81, alongside trailing twelve month revenue of US$50.0 million and EPS of US$3.16 that reflect a 54.1% earnings gain over the past year versus a 6.8% per year earnings decline across the last five years. Over that period, revenue has moved from US$42.4 million and EPS of US$2.07 on a trailing basis in late 2024 to the latest trailing revenue of US$50.0 million and EPS of US$3.16, while the...

Sirius XM Holdings (NasdaqGS:SIRI) has appointed Eve Konstan as Executive Vice President, Chief Legal Officer and Secretary. Konstan succeeds Richard N. Baer, who is retiring from the company. Sirius XM Holdings, known for its subscription based satellite and online audio services, sits at the intersection of radio, streaming and connected car entertainment. The addition of Eve Konstan, who brings legal experience from Spotify, WarnerMedia and HBO, arrives as audio platforms continue to...

AbbVie (ABBV) is back in focus after its latest results showed immunology therapies like Skyrizi and Rinvoq offset the hit from Humira's patent expiration, pushing revenue above analyst estimates despite a miss on full-year EPS guidance. See our latest analysis for AbbVie. At a share price of $223.01, AbbVie has seen short term share price return softness over the past month alongside a 90 day share price return of 5.21%. Its 1 year total shareholder return of 25.34% and 5 year total...

AQR Capital Management, Davis Selected Advisers, and other institutional investors have recently increased their holdings in Tyson Foods. Their moves reflect confidence in margin recovery, ongoing restructuring, and a stabilizing protein cycle at Tyson Foods. This shift in institutional ownership has not yet been widely discussed, despite potential implications for NYSE:TSN. Tyson Foods (NYSE:TSN) is drawing fresh attention as respected value and quantitative managers raise their exposure...

In late January 2026, Baird downgraded Array Technologies from Outperform to Neutral, citing valuation concerns and the risk that intensifying competition could pressure margins on future solar-tracker bookings. The move highlights a growing tension between analyst caution on profitability and investor optimism that Array Technologies can continue winning sizable project orders. We’ll now examine how this downgrade, and the concern over potential margin pressure, shapes Array Technologies’...

In January 2026, Jabil announced a minority investment and manufacturing collaboration with Eagle Harbor Technologies to combine its global production capabilities with EHT Semi’s advanced RF and pulsed DC power systems for next-generation semiconductor fabrication. This partnership gives Jabil direct exposure to highly specialized tools for high aspect ratio etch and atomic layer processes, tightening its link to leading-edge chip manufacturing flows. We’ll now look at how this...

If you are wondering whether GitLab's current share price reflects its true worth, this article will walk through the numbers in a clear and practical way. GitLab's share price closed at US$34.98, with a 3.8% decline over 7 days, a 3.3% decline over 30 days, a 3.3% decline year to date, and a 51.9% decline over the past year. These figures may change how you think about its risk and potential. Recent coverage has focused on GitLab as a standalone DevOps platform and its role in helping...

If you are wondering whether Apple stock still offers value at today's price, this article walks through the numbers so you can judge for yourself. Apple shares last closed at US$259.48, with returns of 4.6% over the past week, a 4.3% decline over the last month, and gains of 10.4% over 1 year, 70.5% over 3 years, and 94.6% over 5 years. These shifts in the share price sit against a backdrop of ongoing product cycles, ecosystem updates, and broader market moves that continue to keep Apple in...

Nova Ltd. recently announced that its Nova Metrion platform has been adopted by global leaders in Memory and Logic device production for Gate-All-Around and advanced DRAM manufacturing, providing fully automated Secondary Ion Mass Spectrometry for inline process control and full-wafer mapping. This adoption is significant because it moves high-precision materials metrology from the lab into the fab, potentially improving yield by enabling near-real-time monitoring of dopant concentration,...

Earnings beat and higher dividend draw investor focus Arthur J. Gallagher (AJG) has come into focus after fourth quarter 2025 results topped market expectations on both revenue and earnings, alongside a higher quarterly dividend that points to ongoing management confidence. The company reported fourth quarter revenue of US$3,628 million, compared with US$2,715 million a year earlier, and net income of US$151 million versus US$258 million. Diluted earnings per share from continuing operations...

Webster Financial Corporation recently reported fourth-quarter and full-year 2025 results, showing higher net interest income and net income compared with the prior year, while its board declared past quarterly cash dividends of US$0.40 per common share and payments on Series F and Series G preferred stock scheduled for March and April 2026. An interesting angle for investors is that these earnings came alongside lower total net charge-offs than a year earlier and completion of a multi-year...

What VEON’s Recent Returns Signal for Investors VEON (VEON) has drawn attention after a mixed run in its share price, with a 1 day decline, a small gain over the past week, and positive returns over the past month and past 3 months. For investors watching telecom and digital operators in emerging markets, these moves sit alongside VEON’s recent fundamentals, including reported revenue of US$4.23b and net income of US$644m, plus annual growth figures in both revenue and net income. See our...

Berkshire Hills Bancorp and Brookline Bancorp have completed their merger of equals to form Beacon Financial Corporation, trading as NYSE:BBT. The combined company reports a larger balance sheet, operational changes and ongoing integration efforts following the merger. Beacon Financial has also declared its first dividend as a newly merged entity. Beacon Financial, now trading at $28.35 under NYSE:BBT, is emerging from this merger as a larger regional player with an expanded footprint. The...

LendingClub (LC) has put accounting in the spotlight after strong fourth quarter and full year 2025 results, as investors weigh the company’s shift to fair value accounting for loans against its upbeat 2026 guidance. See our latest analysis for LendingClub. LendingClub’s 1 day share price return of 2.86% comes after a sharp 7 day share price decline of 19.67%, as the fair value accounting shift and leadership changes land alongside strong 2025 earnings. Its 1 year total shareholder return of...

NASA previously selected Intuitive Machines from a field of 34 volunteer providers to help track the Artemis II mission, using the company’s Space Data Network and one-way Doppler approach, with no direct funding attached to the engagement. This non-paid role still places Intuitive Machines inside a critical human-spaceflight program, spotlighting its technical capabilities and ambitions in broader space infrastructure services. Next, we’ll examine how the Artemis II tracking role influences...

Why Corvus Pharmaceuticals Stock Is on Investors’ Radar Corvus Pharmaceuticals (CRVS) has drawn attention after large price swings recently, with the share price up sharply over the past month and past 3 months, prompting closer scrutiny of its clinical stage pipeline. See our latest analysis for Corvus Pharmaceuticals. The recent 30 day share price return of 182.79% and 90 day return of 169.53% sit alongside a very large 3 year total shareholder return, which points to strong momentum...

Teva Pharmaceutical Industries reported its 2025 results on January 28, 2026, with revenue rising to US$17.26 billion and net income improving to US$1.41 billion, alongside continued momentum in branded drugs like AUSTEDO, UZEDY, and AJOVY. The earnings release underscored Teva’s ongoing shift from a primarily generics-focused business toward higher-margin innovative medicines, supported by cost savings initiatives and late-stage pipeline progress. We’ll now examine how Teva’s improving...

Interest around Rithm Capital (RITM) has picked up as investors look ahead to its fourth quarter 2025 results, expected revenue and earnings pressure in key segments, and fresh analyst coverage tied to recent acquisitions. See our latest analysis for Rithm Capital. Rithm Capital’s recent 1 day share price return of 8.22% decline and 7 day share price return of 7.13% decline, alongside heavier trading and fresh UBS coverage tied to the Paramount Group and Crestline deals, contrast with a 1...

Thermon Group Holdings recently reported quarterly results that beat market expectations and lifted its full‑year revenue and adjusted earnings guidance, reflecting strong demand for its industrial process heating and thermal management solutions. Investors also reacted to consistent earnings-per-share growth over the last three years and ongoing insider share purchases, which together point to visible management confidence and shareholder alignment. Next, we’ll examine how Thermon’s...

Intellia Therapeutics (NTLA) attracted investor attention after the FDA removed the clinical hold on its MAGNITUDE-2 Phase 3 trial. This decision allows enrollment to resume under tighter liver safety monitoring protocols. See our latest analysis for Intellia Therapeutics. The FDA decision arrives after a sharp run, with a 30 day share price return of 42.78% and a year to date share price return of 42.78%, yet the 3 year total shareholder return of 69.58% and 5 year total shareholder return...

In recent months, Occidental Petroleum has seen its fortunes tied closely to rapidly rising WTI crude prices, even as its latest quarterly results showed lower revenue but adjusted earnings per share that exceeded analyst expectations. This combination of stronger oil prices, mixed financial performance and generally cautious analyst views is reshaping how investors weigh the company’s risk‑reward profile. With rising WTI crude prices as a key backdrop, we’ll now examine how these...

UWM Holdings CEO Mat Ishbia has sold a large block of shares under a prearranged 10b5-1 trading plan. The transaction represents a substantial reduction in his indirect stake in NYSE:UWMC. Investors are watching the sale closely given ongoing pressure in the mortgage market. UWM Holdings, trading on the NYSE as UWMC, last closed at $4.91, with the stock showing an 11.3% gain over the past month and a 27.8% return over three years, while the one-year return stands at an 11.9% decline and the...